Abbott Laboratories (
) will begin trading ex-dividend on April 11, 2014. A cash dividend
payment of $0.22 per share is scheduled to be paid on May 15, 2014.
Shareholders who purchased ABT stock prior to the ex-dividend date
are eligible for the cash dividend payment. This represents an
57.14% increase over the same period a year ago. At the current
stock price of $37.63, the dividend yield is 2.34%.
The previous trading day's last sale of ABT was $37.63,
representing a -7.06% decrease from the 52 week high of $40.49 and
a 15.08% increase over the 52 week low of $32.70.
ABT is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Novartis AG (
). ABT's current earnings per share, an indicator of a company's
profitability, is $1.62. Zacks Investment Research reports ABT's
forecasted earnings growth in 2014 as 9.56%, compared to an
industry average of -.7%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to ABT through an Exchange
Traded Fund [ETF]?
The following ETF(s) have ABT as a top-10 holding:
- Vanguard Dividend Appreciation ETF (
- WisdomTree Low P/E Fund (
- iShares U.S. Medical Devices ETF (
- Guggenheim BulletShares 2015 Corporate Bond ETF (
- Schwab U.S. Large-Cap Value ETF (
The top-performing ETF of this group is IHI with an increase of
8.49% over the last 100 days. VIG has the highest percent weighting
of ABT at 3.91%.